Surmodics, Inc. Announces Shawn T McCormick to Resign as Member of the Board of Directors, Effective December 15, 2020
November 18, 2020 at 04:08 pm EST
Share
Surmodics, Inc. announced that on November 13, 2020, Shawn T McCormick, a member of the Board of Directors of the company, informed the company of his intention to resign from its Board of Directors. Mr. McCormick's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices. In order to assure the orderly board oversight of the preparation and filing of the company's Annual Report on Form 10-K for the fiscal year ended September 30, 2020 (the Form 10-K), Mr. McCormick will continue to serve as a director of the company through December 15, 2020, past the anticipated filing date of the Form 10-K.
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
SURMODICS, INC. 
